Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BELATACEPT Cause Intentional product use issue? 83 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Intentional product use issue have been filed in association with BELATACEPT (NULOJIX). This represents 2.4% of all adverse event reports for BELATACEPT.

83
Reports of Intentional product use issue with BELATACEPT
2.4%
of all BELATACEPT reports
4
Deaths
20
Hospitalizations

How Dangerous Is Intentional product use issue From BELATACEPT?

Of the 83 reports, 4 (4.8%) resulted in death, 20 (24.1%) required hospitalization, and 2 (2.4%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BELATACEPT. However, 83 reports have been filed with the FAERS database.

What Other Side Effects Does BELATACEPT Cause?

Off label use (304) Death (206) Transplant rejection (178) Cytomegalovirus infection (142) Drug ineffective (142) Product storage error (142) Acute kidney injury (137) Covid-19 (129) Hospitalisation (123) Kidney transplant rejection (97)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which BELATACEPT Alternatives Have Lower Intentional product use issue Risk?

BELATACEPT vs BELIMUMAB BELATACEPT vs BELINOSTAT BELATACEPT vs BELUMOSUDIL BELATACEPT vs BELVIQ BELATACEPT vs BELZUTIFAN

Related Pages

BELATACEPT Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue BELATACEPT Demographics